RetroSense Therapeutics Company

RetroSense Therapeutics is a biotechnology company developing gene therapy for vision restoration.
Investors
Industry:
Gene Therapy
Technology:
Neurological Disorders
Funding Status:
M&A
Estimated Revenue:
Less than $1M
Investors Number:
12
Headquarters:
Ann Arbor, Michigan, United States
Total Funding:
$106M
Founded Date:
2009
Last Funding Type:
Venture - Series Unknown